SCHEMBL19964787

SCHEMBL19964787

N#Cc1cc(Oc2ccccc2)n2nccc2n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.48
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
GLA P06280 1/20 0.48
POLB P06746 1/20 0.48
HPGD P15428 1/20 0.48
LOXL2 Q9Y4K0 1/20 0.45
LMNA P02545 2/20 0.42
KDM4E B2RXH2 2/20 0.42
MAPT P10636 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
ADRB2 P07550 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
CHEK2 O96017 1/20 0.36
LTA4H P09960 1/20 0.36
CYP1A2 P05177 2/20 0.36
CYP2C19 P33261 2/20 0.36
CSNK1A1 P48729 1/20 0.35
CSNK1D P48730 1/20 0.35
PDE10A Q9Y233 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19964786 0.78 PDE10A (0.54) LOXL2LTA4HPDE10AKCNN1KCNN2
SCHEMBL30904901 0.75 KDM4E (0.44) SMN1; SMN2MEN1KMT2AGLAPOLB
SCHEMBL17787543 0.71 CHEK1 (0.43) KDM4EMAPTCSNK1A1PDE10AGAA
SCHEMBL7833635 0.70 LOXL2 (0.48) LOXL2MAPTL3MBTL1LTA4HCYP1A2
SCHEMBL7835390 0.70 LOXL2 (0.51) MEN1KMT2ALOXL2LTA4HPDE10A
SCHEMBL31091400 0.68 ALDH1A1 (0.40) SMN1; SMN2MEN1KMT2APOLBHPGD
SCHEMBL2177472 0.65 DYRK1A (0.44) MAPTCYP1A2CYP2C19PDE10AGAA
SCHEMBL1680654 0.64 SMN1; SMN2 (0.47) SMN1; SMN2MEN1KMT2AGLAPOLB
SCHEMBL19697639 0.64 SMN1; SMN2 (0.51) SMN1; SMN2MEN1KMT2AGLAPOLB
SCHEMBL30938605 0.64 SMN1; SMN2 (0.51) SMN1; SMN2MEN1KMT2AGLAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018048930-A1 LYSYL OXIDASE-LIKE 2 INHIBITORS AND USES THEREOF PHARMAKEA, INC. (US) 2018-03-15 WO disclosed